Navigation Links
ISMPP Applauds AAMC Clarification on Ghostwriting Versus Transparent Writing Collaboration in Scientific Publications
Date:7/7/2008

The Association of American Medical Colleges (AAMC) recently approved guidelines "Industry Funding of Medical Education" not only addresses funding of medical education, but also provides guidelines to help medical schools and teaching hospitals better manage their relationships with industry. An important element of these guidelines is the clear separation of ghostwriting versus transparent writing collaboration in scientific publications. Unfortunately, the medical writer's role is poorly understood by many, but the International Society of Medical Publication Professionals (ISMPP) is working to clarify these misconceptions by defining the legitimate role of the medical writer while also supporting complete and transparent disclosure. ISMPP concurs with organizations like AAMC who increase recognition and understanding of the many issues involved in the collaborative process of medical writing and publication planning.

Ewing, NJ (PRWEB) July 7, 2008 -- The Association of American Medical Colleges (AAMC) recently approved guidelines, "Industry Funding of Medical Education" (www.aamc.org/industryfunding) not only addresses funding of medical education, but also provides guidelines to help medical schools and teaching hospitals better manage their relationships with industry. An important element of these guidelines is the clear separation of ghostwriting versus transparent writing collaboration in scientific publications.

"Unfortunately, the medical writer's role is poorly understood by many", said Gene Snyder, President of the International Society of Medical Publication Professionals (ISMPP). "ISMPP is working to clarify these misconceptions by defining the legitimate role of the medical writer while also supporting complete and transparent disclosure. We concur with organizations like AAMC who increase recognition and understanding of the many issues involved in the collaborative process of medical writing and publication planning".

AAMC has appropriately defined ghostwriting "as the provision of written material that is officially credited to someone other than the writer(s) of the material. Transparent writing collaboration with attribution between academic and industry investigators, medical writers, and/or technical experts is not ghostwriting. The unacknowledged, undisclosed provision of content should not be permitted under any circumstances". AAMC further provides the following recommendation: "Academic medical centers should prohibit physicians, trainees, and students from allowing their professional presentations of any kind, oral or written, to be ghostwritten by any party, industry or otherwise."

"Heightened awareness and rigorous examination of academic and industry involvement with clinical publications has become an increasingly prevalent topic in the medical literature. As is often the case with media scrutiny, attribution of poor practices in one area are generalized to a larger characterization of the issue at large, albeit unjustly in many cases", said Al Weigel, Chairman of ISMPP's Ethics Committee. "AAMC's guidelines provide a clear distinction between medical writing and ghostwriting/ghost authoring that is in line with the ISMPP Code of Ethics (http://www.ismpp.org), which is intended to promote quality clinical publication practices."

About ISMPP:
The International Society for Medical Publication Professionals is an independent nonprofit professional association with members from the pharmaceutical, medical device, and biotechnology industries; publication planning and medical communications companies; academia; and medical journal staff, including editors and publishers. Its goals are to support the education needs of publication professionals and to develop best practices that ensure the rigorous maintenance of all ethical standards for reporting the results of medical research. Additional information about ISMPP is available by contacting the organization's Executive Director, Kimberly Goldin (phone 914-945-0507, e-mail kgoldin@ismpp.org), or online at http://www.ismpp.org.

###


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Orchid Cellmark Applauds Expansion of Federal Forensic DNA Identity Testing to Include All Arrestees
2. Childhood Influenza Immunization Coalition Applauds Expanded Influenza Vaccine Recommendation for Children
3. Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
4. FRC Applauds New Ballot Initiative for Cures Without Cloning
5. Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings
6. New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
7. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
8. U-M research: New plastic is strong as steel, transparent
9. Facelift for Resumes Offers Hope for Job Seekers, says Resume Writing Service
10. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
11. Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ISMPP Applauds AAMC Clarification on Ghostwriting Versus Transparent Writing Collaboration in Scientific Publications
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):